Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $9.2900 (3.68%) ($9.2900 - $9.4150) on Fri. Feb. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.27% (three month average) | RSI | 25 | Latest Price | $9.2900(3.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -6.4% a day on average for past five trading days. | Weekly Trend | CGEN declines -12.5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(73%) ARKG(72%) ARKK(69%) IWO(67%) IBB(65%) | Factors Impacting CGEN price | CGEN will decline at least -2.135% in a week (0% probabilities). VIXM(-45%) VXX(-40%) UUP(-21%) IGOV(-6%) TBT(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.135% (StdDev 4.27%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-9.06(-197.52%) | Inflection Point | Yes | Resistance Level | $12.24 | 5 Day Moving Average | $10.16(-8.56%) | 10 Day Moving Average | $11.46(-18.94%) | 20 Day Moving Average | $12.24(-24.1%) | To recent high | -34.6% | To recent low | 3.7% | Market Cap | $768m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |